Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 7Sarcoma 5Gastrointestinal 3Head & Neck 2Dermatologic 2Thoracic 1Other solid neoplasm 1Genitourinary 1Endocrine 1Breast 1

Conditions

Melanoma 36Carcinoma, Non-Small-Cell Lung 8Neoplasms 6Colorectal Neoplasms 6Carcinoma, Renal Cell 5Breast Neoplasms 5Stomach Neoplasms 4Neoplasm Metastasis 4Lymphoma, Follicular 4Uveal Melanoma 3Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Carcinoma, Ovarian Epithelial 3Carcinoma, Merkel Cell 3Thyroid Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2

Interventions

pembrolizumab 4Drug Therapy 3Temozolomide 2Radiation 2Paclitaxel 2Nivolumab 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1selinexor 1rovalpituzumab tesirine 1regorafenib 1pazopanib 1niraparib 1imetelstat 1fludarabine 1erythromycin propionate-N-acetylcysteinate 1epacadostat 1efineptakin alfa 1durvalumab 1dostarlimab 1cobimetinib 1cediranib 1cc-486 1carboxyamido-triazole 1bemcentinib 1aflibercept 1WP1066 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Cisplatin × Dermatologic × Clear all
NCT04521686 2026-04-22

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Eli Lilly and Company

Phase 1 Active not recruiting
200 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡